
Sign up to save your podcasts
Or


CDK4/6 inhibitors are used to treat both early-stage and advanced-stage hormone receptor-positive, HER2-negative breast cancer.
The CDK4/6 inhibitors are:
At the 2023 San Antonio Breast Cancer Symposium, Dr. Stephanie Graff moderated an educational session to help people and their doctors decide on treatments after a CDK4/6 inhibitor has stopped working.
Listen to the podcast to hear Dr. Graff explain:
By Breastcancer.org4.3
4242 ratings
CDK4/6 inhibitors are used to treat both early-stage and advanced-stage hormone receptor-positive, HER2-negative breast cancer.
The CDK4/6 inhibitors are:
At the 2023 San Antonio Breast Cancer Symposium, Dr. Stephanie Graff moderated an educational session to help people and their doctors decide on treatments after a CDK4/6 inhibitor has stopped working.
Listen to the podcast to hear Dr. Graff explain:

22,012 Listeners

1,100 Listeners

2,034 Listeners

1,694 Listeners

2,628 Listeners

3,508 Listeners

9,266 Listeners

53 Listeners

4,493 Listeners

329 Listeners

382 Listeners

20,182 Listeners

1,187 Listeners

122 Listeners

30 Listeners